Kim Christopher

Apimeds Pharmaceuticals US, Inc · Chairman and CMO

Kim Christopher is listed in public filings as director, officer: Chairman and CMO. This Kim Christopher insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Apimeds Pharmaceuticals US, Inc (APUS). Investors use Kim Christopher's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Apimeds Pharmaceuticals US, IncAPUS$5.8k3k sharesGrant / ExerciseOct 15, 2025$5.8K3k shares$1.92--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Historical actions before the latest disclosure date will appear here after more snapshots are available.